Table
2: Clinical
data of patients with PHT and patients without PHT
Parameters |
Patients without PHT |
Patients with PHT |
P |
Number of patients |
24 (40%) |
36 (60%) |
|
Age (years) |
52.6 ± 12 |
58 ± 10 |
> 0.05 |
Sex (n,%) Male:
32 (53.3%) Female: 28
(46.7%) |
13 (21.7%) 11 (18.3%) |
19 (31.7 %) 17 (28.3%) |
> 0.05 |
Etiology of renal disease: (n, %) Diabetic nephropathy 20(33.3%) HTN 15 (25%) Glomerulonephritis 7 (11.7%) Obstructive
uropathy 5 (8.3%) ADPKD 2 (3.3%) Ch.
Pyelonephritis 5 (8.3%) Undetermined
renal 6
(10%) |
5 (25%) 5 (33.3%) 4 (57.1%) 2 1 2 6 |
15 (75%) 10 (66.7%) 3 (42.9%) 3 1 3 |
> 0.05 |
Antihypertensives (n, %) Ca channel blockers Beta blockers ACE inhibitors Antidiabetics (n, %) Insulin Valdagliptin No treatment Hemodialysis (n, %) Predialysis CKD patients Hemodialysis patients Shunt location (n %) Brachial Radial |
16 (34.8%) 7(15.8%) 3(6.5%) 6(13%) 5(25%) 3(15%) 2(10%) 0 17(56.7%) 7(23.3%) 00 7(33.3%) |
30 (65.2%) 14(30.4%) 1(2.2%) 15(32.6%) 15(75%) 8(40%) 4(20%) 3(15%) 13(43.3%) 23(76.7%) 9(100%) 14(66.7%) |
> 0.05 > 0.05 < 0.005 < 0.05 |